Nad+ Nicotinamide Adenine Dinucleotide recalls
The FDA has published 4 recalls involving Nad+ Nicotinamide Adenine Dinucleotide since 2022. The latest was reported on 15 Oct 2025. Most were for sterility. GenoGenix has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls4since 2022
Last 12 months2reported
Class I125% of total
Ongoing2latest 15 Oct 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 25%Class II 3 75%Class III 0 0%
Why nad+ nicotinamide adenine dinucleotide is recalled
Companies
By year
Ongoing nad+ nicotinamide adenine dinucleotide recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | NAD+ (Nicotinamide adenine dinucleotide) for Injection recalled | GenoGenix | Sterility | Nationwide |
| Drug | CLASS II | NAD+ (Nicotinamide adenine dinucleotide), a) 50 mg/mL recalled | GenoGenix | Sterility | Nationwide |
All nad+ nicotinamide adenine dinucleotide recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | NAD+ (Nicotinamide adenine dinucleotide) for Injection recalled | GenoGenix | Sterility | Nationwide |
| Drug | CLASS II | NAD+ (Nicotinamide adenine dinucleotide), a) 50 mg/mL recalled | GenoGenix | Sterility | Nationwide |
| Drug | CLASS II | NAD+ Nicotinamide Adenine Dinucleotide recalled | Olympia Compounding Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | NAD+ Nicotinamide Adenine Dinucleotide recalled | Olympia Compounding Pharmacy | Other | Nationwide |
Should you stop taking Nad+ Nicotinamide Adenine Dinucleotide?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.